| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Alzheimers disease and mirna effects 0.4389558758528688 2.7715618478166095 0.0055788073107867 0.9643597078001768 0.4953182298345657 88 P28072,Q9H0B6,P31751,Q08209,Q9NQC3,O95197,P28074,P20618,P28070,P31749,P33176,P21796,P25054,P49721,P45880,Q99436,P0DP25,P16615,O14641 19 |
| Alzheimers disease 0.4430058928949361 2.7472133994802546 0.0060104013383257 0.9724845539106012 0.4953182298345657 87 P28072,Q9H0B6,P31751,Q08209,Q9NQC3,O95197,P28074,P20618,P28070,P31749,P33176,P21796,P25054,P49721,P45880,Q99436,P0DP25,P16615,O14641 19 |
| Striated muscle contraction pathway 0.8695803697817827 2.5379186267634655 0.0111513909797036 0.9987486898942728 0.4953182298345657 7 P35609,P06753,P08670,P09493,P67936 5 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.699400184424039 2.521666357479708 0.0116800432461696 0.99909019413094 0.4953182298345657 15 O60725,O75844,P55209,P25054 4 |
| Embryonic stem cell pluripotency pathways 0.7206782803649449 2.488521505848219 0.0128275478774955 0.9995447558294884 0.4953182298345657 13 P31749,P25054,P31751 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.7073785726159176 2.4157163047948313 0.0157042917364118 0.9999200437291046 0.4953182298345657 13 P31749,Q05086,P31751 3 |
| Nocgmppkg mediated neuroprotection 0.8153847830026167 2.400698911375024 0.0163637945072585 0.9999463752290524 0.4953182298345657 8 P35609,P07196,P30536,Q99996,P16220 5 |
| Head and neck squamous cell carcinoma 0.6093516816556042 2.3731117389651595 0.017638926850952 0.9999752484533666 0.4953182298345657 19 P49815,P31749,P31751 3 |
| Endometrial cancer 0.6628183087327262 2.307971935063303 0.0210006974957401 0.9999967915158184 0.4953182298345657 15 P31749,P31751 2 |
| Relationship between inflammation cox2 and egfr 0.8320051310396293 2.2816598007103304 0.0225094331535877 0.9999987203397216 0.4953182298345657 6 P31751 1 |
| Oxidation by cytochrome p450 0.8734044571287873 2.2384455479101915 0.0251920145839004 0.999999751245703 0.4953182298345657 5 O43169,Q16850,Q6UW02 3 |
| Sphingolipid metabolism overview 0.7568886805744015 2.233926987408688 0.0254878775183677 0.99999979241376 0.4953182298345657 9 Q16739,Q06136,Q96G23 3 |
| Sphingolipid metabolism integrated pathway 0.7568886805744015 2.233926987408688 0.0254878775183677 0.99999979241376 0.4953182298345657 9 Q16739,Q06136,Q96G23 3 |
| Chromosomal and microsatellite instability in colorectal cancer 0.5700265027720173 2.2270077658758436 0.0259467547773102 0.9999998432210409 0.4953182298345657 20 P31749,P31751 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.8643899134057536 2.2014226262823664 0.0277061186708034 0.9999999466245648 0.4953182298345657 5 O95470,Q16739,Q06136 3 |
| Resistin as a regulator of inflammation 0.786550278414611 2.1715354122108 0.0298907232974456 0.999999986032718 0.4953182298345657 7 P31751 1 |
| Mitochondrial complex iv assembly 0.6621919440409341 2.1636942503039003 0.03048782257808 0.9999999903228396 0.4953182298345657 13 Q9Y2R0,P00403,Q53S58,P13073,P14406 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7828462700846479 2.1548250382711234 0.0311755281384749 0.9999999936601388 0.4953182298345657 7 Q14739,Q15392,Q16850,Q15125 4 |
| Melanoma 0.6236855927616192 2.154092108248766 0.0312329493105498 0.9999999938801868 0.4953182298345657 16 P31749,P0DP25,P31751 3 |
| Kisspeptinkisspeptin receptor system in the ovary 0.8002234551452503 2.1438965448701417 0.032041177112865 0.9999999962786364 0.4953182298345657 6 P31751 1 |
| Influence of laminopathies on wnt signaling 0.6906761904925848 2.132692348243716 0.0329499720237977 0.9999999978739704 0.4953182298345657 11 O75844,O60725,P25054 3 |
| Tolllike receptor signaling pathway 0.6753532490699264 2.0513427328389646 0.0402335817298642 0.9999999999765216 0.4953182298345657 11 P31751 1 |
| Cardiac hypertrophic response 0.6382136724638644 2.0270289653610893 0.0426594505249999 0.9999999999948048 0.4953182298345657 13 P31749,P31751 2 |
| Sphingolipid pathway 0.6918710450260541 2.0210671564599605 0.0432728136769264 0.9999999999964542 0.4953182298345657 10 Q16739,Q06136,Q96G23 3 |
| Bdnftrkb signaling 0.6458892306465571 2.016692858075732 0.043727575708405 0.9999999999973292 0.4953182298345657 12 P31749,Q15418,P49815,P62993,P16220 5 |
| Wnt signaling pathway 0.6237392001262009 2.003939347598231 0.0450765579426557 0.9999999999988484 0.4953182298345657 14 O14641,P25054,P31749 3 |
| Kennedy pathway from sphingolipids 0.7677679239562167 2.0010133461952506 0.0453909516426609 0.9999999999990538 0.4953182298345657 6 O95470,Q9HBU6,P35790 3 |
| Translation inhibitors in chronically activated pdgfra cells 0.5331346460378351 1.958656148623087 0.0501530691774767 0.999999999999952 0.4953182298345657 20 P31749,Q15418,Q14240,P31751 4 |
| Proteoglycan biosynthesis 0.8581581285164305 1.9501651537704496 0.0511564376319224 0.9999999999999744 0.4953182298345657 4 Q8NCH0,Q9NX62,Q8TB61 3 |
| Camkk2 pathway 0.6248546991077994 1.9500180334303208 0.05117396968711 0.9999999999999748 0.4953182298345657 13 O00429,P09601,P16220 3 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.6297500089297522 1.925999745622144 0.0541044056078885 0.999999999999996 0.4953182298345657 12 P31751 1 |
| Nanomaterial induced apoptosis 0.7954640209142019 1.9134580984171736 0.055689432798663 0.9999999999999986 0.4953182298345657 5 O95831,Q9NR28 2 |
| Tcell activation sarscov2 0.5854018001226147 1.9132510342113491 0.0557159229951889 0.9999999999999986 0.4953182298345657 16 P31749,P49841,Q15382,O15111,P49815,P62993,Q07812 7 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.7945470507139197 1.909570518150102 0.0561885340815759 0.9999999999999988 0.4953182298345657 5 P08670 1 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.6697860966811792 1.90706000069479 0.0565128181690444 0.9999999999999992 0.4953182298345657 10 P31751 1 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.9401368856953404 1.899536501861257 0.0574939720366602 0.9999999999999996 0.4966145990412975 3 P31751 1 |
| Vitamin a and carotenoid metabolism 0.7435614217785824 1.8930339746806424 0.0583533514751697 0.9999999999999998 0.4968371068457309 6 O94788,Q8WTV0 2 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8372839441408395 1.8660100498549783 0.062039959452711 1.0 0.5034114758916068 4 P09601 1 |
| Cell migration and invasion through p75ntr 0.7835185067796429 1.8627026743401935 0.0625041094227834 1.0 0.5034114758916068 5 P31751 1 |
| Sphingolipid metabolism in senescence 0.6158164739138765 1.847015991285783 0.0647448226863165 1.0 0.5145055242805954 12 Q16739,Q96G23 2 |
| Nitric oxide metabolism in cystic fibrosis 0.8296632140007942 1.83513301764586 0.0664859828116584 1.0 0.5213900757335317 4 O60678 1 |
| Mitochondrial complex iii assembly 0.6310003531186783 1.8118628674490929 0.0700073881885454 1.0 0.5361847206518655 11 Q9UDW1,P22695,O14949 3 |
| Ccl18 signaling pathway 0.6710528235098575 1.810799938480006 0.0701718258571233 1.0 0.5361847206518655 9 P08670,P07196,P00403,P33176 4 |
| Endothelin pathways 0.7011399964762466 1.7784831123240616 0.0753245431344078 1.0 0.560016612357888 7 P16615,P42892,P00403 3 |
| Amyotrophic lateral sclerosis als 0.6230119524246197 1.7681173894158615 0.077041280909184 1.0 0.560016612357888 11 P07197,P07196 2 |
| Neural crest cell migration during development 0.6780928503717115 1.7531108334525878 0.0795829843306576 1.0 0.560016612357888 8 P31751 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7562203791469128 1.7458391948296903 0.0808388981319538 1.0 0.560016612357888 5 P49841,Q07820,Q9BXK5,P31749 4 |
| Nonsmall cell lung cancer 0.5696128505477609 1.7401335618979683 0.0818355682629676 1.0 0.560016612357888 15 P31751 1 |
| Neural crest cell migration in cancer 0.6569714615991293 1.7396257072264287 0.0819247622319292 1.0 0.560016612357888 9 P31751 1 |
| Disruption of postsynaptic signaling by cnv 0.6564510941413408 1.7369866365203357 0.0823895296895507 1.0 0.560016612357888 9 Q06787,Q13555,Q7L576,P27361,Q14168 5 |
| Familial partial lipodystrophy fpld 0.6890468171456952 1.7215854591592024 0.0851446391121937 1.0 0.560016612357888 7 O60725,P31751 2 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5938956265593872 1.7215115328020605 0.0851580412396497 1.0 0.560016612357888 12 O60333,Q9NR77,P07196,P50570 4 |
| Electron transport chain oxphos system in mitochondria 0.478546629120635 1.719596063909409 0.0855058921553151 1.0 0.560016612357888 53 P00846,O75964,Q9UDW1,P22695,P00403,P56556,P03886,O14949,P06576,O96000,P13073,O43676,P14406 13 |
| Micrornas in cardiomyocyte hypertrophy 0.4990134887188744 1.704226022574182 0.0883388693974562 1.0 0.571861224968178 20 Q08209,P31749,P49841,P31751,O75116 5 |
| Genes related to primary cilium development based on crispr 0.5631318648617913 1.6994555706974266 0.0892333790638264 1.0 0.571861224968178 15 Q7Z4L5,Q8WXW3,O95684,Q8NCM8,Q10713 5 |
| Mecp2 and associated rett syndrome 0.4981431897369389 1.6852636086917892 0.0919377235498635 1.0 0.5767882445865122 23 P67809,P31749,Q05086,P35637,P52597,P16220,Q03518 7 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.6789133019037695 1.6736906431804306 0.0941914136514481 1.0 0.5788060626567595 7 P49815,P31749,P49841 3 |
| Metapathway biotransformation phase i and ii 0.4961515332767037 1.673638547640178 0.0942016578484994 1.0 0.5788060626567595 22 Q8NCH0,Q6UW02,Q16850,P78417 4 |
| Triacylglyceride synthesis 0.878878913405901 1.6624336498872545 0.0964258566016624 1.0 0.5805031367130387 3 Q9HCL2 1 |
| Erk pathway in huntingtons disease 0.775502492942468 1.613535868794402 0.1066281370293333 1.0 0.5995317893347424 4 P42858 1 |
| Spinal cord injury 0.4844219842747642 1.5885367515354123 0.1121650174169601 1.0 0.6083241916057821 21 P62942,Q08209,P08670,Q9NQC3,O75116,P14174 6 |
| T cell receptor and costimulatory signaling 0.7148357931883305 1.566559318183421 0.11721773318686 1.0 0.6182457431802528 5 Q08209,P31749 2 |
| Extracellular vesiclemediated signaling in recipient cells 0.6698832839185835 1.5575605128262118 0.1193374653589081 1.0 0.6228900671042269 6 P31749 1 |
| Ranklrank signaling pathway 0.5295768288719971 1.5519606662871188 0.1206716354545938 1.0 0.6228900671042269 16 P31749,P31751 2 |
| Myometrial relaxation and contraction pathways 0.4745555659015169 1.512966264468545 0.1302882282865516 1.0 0.6541314013002807 21 P16615,P78417,P0DP25 3 |
| Pancreatic adenocarcinoma pathway 0.4750416237689983 1.5117134594934063 0.1306067730784117 1.0 0.6541314013002807 22 P31751 1 |
| Estrogen receptor pathway 0.9689257176679492 1.483344450031039 0.1379829182010961 1.0 0.6717359146515984 2 Q9HCL2 1 |
| Reninangiotensinaldosterone system raas 0.7434535287116064 1.4809118572865525 0.1386300629230648 1.0 0.6717359146515984 4 P0DP25,P16220 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6513666652409403 1.4718628417819664 0.1410579195879118 1.0 0.6725641605951634 6 P25054 1 |
| Wntbetacatenin signaling pathway in leukemia 0.6462213669635484 1.4479705036662105 0.1476253000209983 1.0 0.6791765831286963 6 P31749 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7334912644358809 1.4395171093891432 0.1500040659523867 1.0 0.6791765831286963 4 P02545,O60725,Q03252 3 |
| Il7 signaling pathway 0.6442135033063696 1.438638418085848 0.1502529955017082 1.0 0.6791765831286963 6 P49841,P31749 2 |
| Small cell lung cancer 0.5384510129121496 1.438043685718075 0.1504216593506508 1.0 0.6791765831286963 13 P31749,P31751,P07942,O15111,P11802 5 |
| Caloric restriction and aging 0.6791614699503383 1.41035621246175 0.1584345279687942 1.0 0.7069208367672793 5 P31749 1 |
| Egfr tyrosine kinase inhibitor resistance 0.516937877121954 1.4057175802275967 0.1598080044775254 1.0 0.7069208367672793 15 P31751 1 |
| Breast cancer pathway 0.4635938873326876 1.4046523344095192 0.1601246861805079 1.0 0.7069208367672793 27 P31749,P25054,P31751 3 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4608562382203351 1.3925948463733928 0.1637423423393182 1.0 0.7166699446944678 24 P48449,Q16850,Q15125,Q9BWD1,Q15800,Q15392,Q14739 7 |
| Tnfalpha signaling pathway 0.4585119034073207 1.3893120213098469 0.1647378899717149 1.0 0.7166699446944678 21 P31749,Q9NR28,Q6GQQ9,P27361,Q16543,P06737,O15111,P62993,Q9Y297,Q07812,Q13200 11 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6185528519112066 1.3848481300885114 0.1660989103588876 1.0 0.717138224343335 7 P16220 1 |
| Physicochemical features and toxicityassociated pathways 0.4588123665744178 1.3810314276380562 0.167269297755473 1.0 0.717138224343335 23 P07197,P07196,P31749 3 |
| S1p receptor signal transduction 0.6002037962503552 1.3675448722893917 0.171454582377537 1.0 0.717138224343335 8 P31751 1 |
| Neural crest differentiation 0.5658400353782229 1.3541205550468502 0.1756979193793304 1.0 0.7172326023978146 10 Q9NR77 1 |
| Nad metabolism 0.7097599404209147 1.3406873314637762 0.1800219894120935 1.0 0.7298850727184202 4 Q8IXJ6 1 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.7050072384275656 1.3208687247443718 0.1865451395815522 1.0 0.7437707752332517 4 Q07820,P31749 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.6036560083043454 1.312831450703407 0.1892397496921765 1.0 0.746933051765147 7 P07900,P00533,Q16543,O00170,P24941 5 |
| Nonalcoholic fatty liver disease 0.4348337663205244 1.2939645622751126 0.1956776618021247 1.0 0.749826301722177 52 P31749,P31751,Q9UDW1,P22695,P00403,O14949,O96000,O43676,Q86Y39,P14406 10 |
| Nad biosynthetic pathways 0.6525009344145962 1.2929496825841804 0.1960284625406676 1.0 0.749826301722177 5 Q8IXJ6 1 |
| Vitamin dsensitive calcium signaling in depression 0.6523058321248332 1.2920892118635543 0.1963262514853871 1.0 0.749826301722177 5 Q8NB78,O60341,P11413 3 |
| Hepatitis b infection 0.4470028876440874 1.2886454986969718 0.1975213580039962 1.0 0.749826301722177 23 P31749,P31751 2 |
| Riboflavin and coq disorders 0.6088964311700575 1.273860846403051 0.2027127365634942 1.0 0.7551049436990159 6 Q8NI60,O75208 2 |
| Glycerolipids and glycerophospholipids 0.5896342203955662 1.2448861603384789 0.2131735988205014 1.0 0.7854596418222027 7 Q9HBU6,Q9HCL2 2 |
| 15q112 copy number variation syndrome 0.6853901469618078 1.2390348078024165 0.2153326078558706 1.0 0.7854596418222027 4 Q7L576,Q9BSJ2 2 |
| Omega3 omega6 fatty acid synthesis 0.6001035611227508 1.2327056582570357 0.2176856000333531 1.0 0.7854596418222027 6 Q15067 1 |
| Angiopoietinlike protein 8 regulatory pathway 0.4430459815926892 1.2325588840102053 0.217740384854016 1.0 0.7854596418222027 32 P31749,P51812,P31751,P49841,P49815,Q15382,Q15418,P13807 8 |
| Complement and coagulation cascades 0.7685942208211569 1.2298081364275413 0.2187689606417544 1.0 0.7854596418222027 3 P10909 1 |
| Glioblastoma signaling pathways 0.4351280556157435 1.2147346775240282 0.224467301962187 1.0 0.7987488117798975 20 P31749,P31751 2 |
| Il17 signaling pathway 0.6750926921512512 1.196090027082242 0.2316614290043852 1.0 0.8072579924084619 4 P49841,P31749 2 |
| Cellular proteostasis 0.6696774552678528 1.1735192360336415 0.2405876475386295 1.0 0.8078060896359848 4 O15212 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.4801696042739309 1.1683444308874449 0.2426678600712244 1.0 0.8078060896359848 15 P35609,P16615,P50402,P12814 4 |
| Wnt signaling 0.4796117581775382 1.1647295346957516 0.2441284898775557 1.0 0.8078060896359848 15 Q08209,P25054,Q13555,O14641,O75116 5 |
| Follicle stimulating hormone fsh signaling pathway 0.5219665570132941 1.115201014982425 0.2647642912318508 1.0 0.848384503087006 10 P16220,P31749 2 |
| Estrogen signaling pathway 0.5615348141746247 1.1085355197432751 0.2676306079097559 1.0 0.851484935261506 7 P31749 1 |
| Apoptosis 0.4993395493128822 1.0728207843002244 0.2833515335170899 1.0 0.851484935261506 11 O15111,Q07820,Q9NR28,P31749 4 |
| Histone modifications 0.5268913827956936 1.0654946392419822 0.2866521502034884 1.0 0.851484935261506 9 Q03164,Q01105 2 |
| Primary focal segmental glomerulosclerosis fsgs 0.415515481616559 1.0549047752531315 0.291468878078456 1.0 0.851484935261506 21 P35579,P08670,P31749 3 |
| Pregnane x receptor pathway 0.6405093278057383 1.0522719072040605 0.2926748167542117 1.0 0.851484935261506 4 Q99615,P08183,P62195 3 |
| Complement system in neuronal development and plasticity 0.4748605142975474 1.0503737181468746 0.2935463242080238 1.0 0.851484935261506 13 O43464,Q9NR28,P10909 3 |
| Progeriaassociated lipodystrophy 0.5236273943187092 1.0484140055607265 0.2944479035291016 1.0 0.851484935261506 9 O75844,O60725 2 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.638115629237982 1.042357789661394 0.2972458286598236 1.0 0.851484935261506 4 P62942 1 |
| Tgfbeta receptor signaling 0.638115629237982 1.042357789661394 0.2972458286598236 1.0 0.851484935261506 4 P62942 1 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.5588156058929887 1.0394592645759313 0.2985911937410315 1.0 0.851484935261506 6 O15111,P00533,P06753,P61201 4 |
| Dna damage response only atm dependent 0.4117864252878261 1.0258406466455403 0.3049667032880703 1.0 0.8574762111858659 21 P31749,P25054,P31751 3 |
| Neuroinflammation 0.6326723219350793 1.0198405651652334 0.3078040810809819 1.0 0.8574762111858659 4 P00403 1 |
| Il9 signaling pathway 0.5520988971619728 1.008114728813975 0.3133993875551297 1.0 0.864660776074029 6 P50750,P62993,P27361 3 |
| Copper homeostasis 0.5154561162450597 1.0056901411994672 0.3145646471005723 1.0 0.864660776074029 9 O75880,P25054,P31749 3 |
| Apoptosis modulation and signaling 0.4718155907159193 1.0019369643956784 0.3163740383392488 1.0 0.864660776074029 12 O43464,O95831,Q9NR28 3 |
| Ciliopathies 0.4064518803021308 0.9842910998150908 0.3249724043233302 1.0 0.8763961673154064 21 Q7Z4L5,Q9UBB4,Q15555,Q8WXW3,Q8NCM8,Q10713 6 |
| Pi3kakt signaling pathway 0.4100656171093609 0.979992012030784 0.3270900616840437 1.0 0.878133679115721 43 P23588,P31751,Q15382,P07942,P11802,Q07820,P31749,P30154,Q9UBI6,Q16513,O15111,P13807,P27361,P30153,P49841,P16220,Q16543,P49815,P62993 19 |
| Serotonin receptor 467 and nr3c signaling 0.6205399957707207 0.9698127511130544 0.3321398358043765 1.0 0.879801520619593 4 P16220 1 |
| Proteasome degradation 0.4057692225668349 0.9373178199655684 0.3485950992265161 1.0 0.9088836965271806 42 P28072,P28070,O00231,Q99436,P51665,P28074,P20618,Q9UL46,P49721,P61289,Q06323 11 |
| Acute viral myocarditis 0.446178969321421 0.9078973239602876 0.36393247160366 1.0 0.9126198825796068 14 Q9NRG0,P31749,P49841,Q04637,P16220,Q07812 6 |
| Mammalian disorder of sexual development 0.6840923312402367 0.9020968017625152 0.3670054476841073 1.0 0.9126198825796068 3 O43251 1 |
| Epo receptor signaling 0.518789788350725 0.9020194564072916 0.3670465323409748 1.0 0.9126198825796068 7 P62993,P31749 2 |
| Regulatory circuits of the stat3 signaling pathway 0.46897382617719 0.9002986777785605 0.3679613245546118 1.0 0.9126198825796068 11 P16949 1 |
| Interleukin11 signaling pathway 0.4495103073472274 0.8956335913792846 0.3704484888820363 1.0 0.9126198825796068 13 P31749,Q15418,O15111,P62993,P16220 5 |
| Pi3kaktmtor vitd3 signaling 0.5245773788390999 0.8803974918508514 0.3786440147726164 1.0 0.9132873442466898 6 P49815,P31749 2 |
| Mthfr deficiency 0.5112565817387495 0.8659410649684651 0.3865224819696644 1.0 0.9201893625486413 7 P21964,P35790 2 |
| Met in type 1 papillary renal cell carcinoma 0.3991752229089588 0.8558479727588207 0.3920818759862432 1.0 0.9201893625486413 19 P31751 1 |
| Interactions between loxl4 and oxidative stress pathway 0.5912185712326865 0.8501366414009968 0.3952491221685439 1.0 0.9201893625486413 4 Q16543,Q8TAG9 2 |
| Nephrotic syndrome 0.4112503281607022 0.8145900001558515 0.4153070363414572 1.0 0.9413530187483128 17 Q7Z4L5,O75844,P35579,O43707 4 |
| Oxidative phosphorylation 0.3906632065527927 0.8020181687373954 0.4225424485133744 1.0 0.9413530187483128 32 P00846,O75964,P56556,P03886,O96000,Q86Y39 6 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.4864941591898987 0.7975783333772857 0.4251152285096968 1.0 0.9413530187483128 8 Q96KB5,P31749 2 |
| Methionine de novo and salvage pathway 0.4966810293159497 0.7965861350267868 0.4256914324296585 1.0 0.9413530187483128 7 Q13126,Q9BV57 2 |
| Erbb signaling pathway 0.3820321792917392 0.795095647952553 0.4265578660435349 1.0 0.9413530187483128 21 P31751 1 |
| Osteopontin signaling 0.5772127704416921 0.7937997949275667 0.4273119920673136 1.0 0.9413530187483128 4 O15111,P27361 2 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.5728786157886657 0.7765014763151704 0.4374529494669015 1.0 0.9416668261869952 4 P16220 1 |
| Adipogenesis 0.4248742433384762 0.7752099213695586 0.4382156265660066 1.0 0.9416668261869952 14 Q9NZ45,P02545,O75844,P16220,P43490,P14174 6 |
| Integrinmediated cell adhesion 0.3822844470107024 0.7739338130998896 0.4389699325821308 1.0 0.9416668261869952 24 P31751 1 |
| Vitamin d receptor pathway 0.4306778175355905 0.7587503178087723 0.4480019305693896 1.0 0.947952876368156 12 P11413,P20020,P49427,Q92604,P09493,P24941,Q96KA5 7 |
| Insulin signaling 0.3827573130775229 0.7539004020936243 0.4509090291409239 1.0 0.947952876368156 46 P31749,P31751,P51812,P33176,Q6ZWJ1,Q15382,P49841,O00159,P49815,P46976,Q15418,P13807,P62993,P10586 14 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4015252059128621 0.7483225464185641 0.4542656281910202 1.0 0.947952876368156 17 Q9BTV4,P33176,O94901,P50402,Q14739,Q8WXH0,P62993 7 |
| Mapk cascade 0.4810314167160657 0.7229695269952324 0.4696986061474901 1.0 0.9631858680858486 7 P45985,Q9UHA4,P62993,P28482,P27361,Q02750 6 |
| Mirna regulation of prostate cancer signaling pathways 0.4785218692409324 0.711263385847546 0.4769210361112903 1.0 0.9631858680858486 7 P49841 1 |
| Ovarian infertility 0.7638354542764162 0.705425654758159 0.4805453832390474 1.0 0.9631858680858486 2 Q8WXH0 1 |
| Serotonin and anxiety 0.763243563184377 0.7033558849579261 0.4818339915052436 1.0 0.9631858680858486 2 Q08209 1 |
| Matrix metalloproteinases 0.7614678899082596 0.6971573084167259 0.4857043527841829 1.0 0.9631858680858486 2 Q9UGU0 1 |
| Supression of hmgb1 mediated inflammation by thbd 0.7564368156259278 0.6796838382122227 0.4967046715840819 1.0 0.9631858680858486 2 P09429 1 |
| Nodlike receptor nlr signaling pathway 0.7564368156259279 0.6796838382122227 0.4967046715840819 1.0 0.9631858680858486 2 Q96RT1 1 |
| Leptininsulin signaling overlap 0.7561408700799086 0.6786601689706108 0.4973532092384007 1.0 0.9631858680858486 2 P31749 1 |
| Translation factors 0.3764653207554627 0.6776156897228466 0.4980153954547022 1.0 0.9631858680858486 37 P23588,P55010,O75153,Q9H074,P29692,Q14240,O15372 7 |
| Ebsteinbarr virus lmp1 signaling 0.6228537596210861 0.6754815735866267 0.4993698544270473 1.0 0.9631858680858486 3 O15111,P07900 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6228537596210808 0.6754815735866082 0.499369854427059 1.0 0.9631858680858486 3 P00533,P27361 2 |
| Photodynamic therapyinduced ap1 survival signaling 0.4486951364175313 0.662389069346137 0.5077219071187535 1.0 0.964523368705846 9 P07900,P04637,P45985,Q07820,P20248,P00533,Q07812,Q16539 8 |
| G1 to s cell cycle control 0.3703687210712983 0.6617133783380461 0.5081549291503953 1.0 0.964523368705846 27 P33991,Q9Y619,P25205,O75419,P33993,Q14566,P06493,Q9UBD5,P16220,P24941,Q13416,P11802 12 |
| Purine metabolism and related disorders 0.4050308153395922 0.628984078576013 0.5293594796706702 1.0 0.9843335578612448 13 P00813 1 |
| Sulfation biotransformation reaction 0.6079299057719145 0.6227391696280979 0.5334559382368826 1.0 0.9843335578612448 3 P11413 1 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.3975673447882739 0.585411883114714 0.5582708004755474 1.0 0.9986330640024844 13 O14641,P25054,Q86UE4 3 |
| Tolllike receptor signaling related to myd88 0.5953226761397363 0.5791774368823991 0.5624694536479875 1.0 1.0 3 O15111,P28482 2 |
| Lipid metabolism pathway 0.4097667755165941 0.5723447930999942 0.5670884091545809 1.0 1.0 11 P31751 1 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3848177621701537 0.5594088438615159 0.5758827270477425 1.0 1.0 15 P08670,P31749 2 |
| Glycogen synthesis and degradation 0.3761527980892696 0.5386636070367616 0.5901189894846173 1.0 1.0 16 P52789,P30154,P0DP25,P46976,P13807 5 |
| Kallmann syndrome 0.5080417915621396 0.5285765856548018 0.5970992064298484 1.0 1.0 4 P31749 1 |
| 3q29 copy number variation syndrome 0.3811818947224669 0.5112330263712161 0.609187895318565 1.0 1.0 14 O95684 1 |
| Glycerophospholipid biosynthetic pathway 0.4259603053065463 0.5089875089679595 0.6107609796164108 1.0 1.0 8 Q9HCL2 1 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.4252506158738648 0.5057594026486337 0.6130255614015514 1.0 1.0 8 P51812,Q15418 2 |
| Target of rapamycin tor signaling 0.3827148581714903 0.5002393399911806 0.616906560912565 1.0 1.0 13 P49815,P31749 2 |
| 16p112 proximal deletion syndrome 0.3480143398520106 0.4974551390857891 0.6188681306216628 1.0 1.0 26 P49368,P78371,P78318,Q6IN85,Q16204 5 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3452362610047612 0.4767768261587152 0.6335210491808789 1.0 1.0 26 P31749,P49841,P31751,Q16625,Q8N3R9 5 |
| Bladder cancer 0.4603080568720243 0.4766034102137211 0.6336445545867198 1.0 1.0 5 P00533,P28482,Q02750,P11802 4 |
| Chemokine signaling pathway 0.3418432424428436 0.475356977832287 0.6345325536423263 1.0 1.0 23 P31751 1 |
| Praderwilli and angelman syndrome 0.4061702472140118 0.4563293927951272 0.6481531307156065 1.0 1.0 9 Q7L576,Q05086,Q15154 3 |
| Melatonin metabolism and effects 0.5523514450182829 0.4390040478453134 0.6606586033098361 1.0 1.0 3 P42892 1 |
| Nanoparticlemediated activation of receptor signaling 0.4164196799051591 0.4347899353467595 0.6637149110587817 1.0 1.0 7 P00533,Q9Y490,P62993,P28482,Q16539,Q02750 6 |
| Ferroptosis 0.3347167247947881 0.4238580242738176 0.6716693583453455 1.0 1.0 23 P09601,Q9UKU0,P16435,P45880 4 |
| Bmp signaling in eyelid development 0.675051790470558 0.4198713879243069 0.6745794106148542 1.0 1.0 2 P27361 1 |
| Folatealcohol and cancer pathway hypotheses 0.5409530284248535 0.4043582558375739 0.6859492923526038 1.0 1.0 3 P16220 1 |
| Heme biosynthesis 0.4400870086009275 0.4019292853829192 0.6877360694235595 1.0 1.0 5 P06132 1 |
| Rac1pak1p38mmp2 pathway 0.346637593215313 0.3902048155985027 0.6963851009839719 1.0 1.0 17 P16949,P31749,P43246,O15111,P62993,Q07812 6 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.5359670369216653 0.3895829896105103 0.6968449325665338 1.0 1.0 3 P27361 1 |
| Burn wound healing 0.3875396540257921 0.3717587788277133 0.7100724571787542 1.0 1.0 9 P08670 1 |
| Il1 signaling pathway 0.3553589335164031 0.3647178153511374 0.7153220586231857 1.0 1.0 14 O15111,Q13501,Q9BQ95,P31749 4 |
| Circadian rhythm genes 0.3361090692988657 0.3533307118224768 0.7238405237545336 1.0 1.0 47 Q8N163,Q05086,Q9UNS1,Q03164,Q8WXF1,P23246,P16220,O75116,Q9Y297,Q15233,P00813,P43490,O15294 13 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.3732402346623391 0.3424880195117369 0.7319836585162773 1.0 1.0 10 P49770,P31749 2 |
| Canonical and noncanonical notch signaling 0.5120575239475266 0.32219973040112 0.7473013887157243 1.0 1.0 3 P55081 1 |
| Urea cycle and related diseases 0.636282923942 0.3156722376824398 0.7522513011073009 1.0 1.0 2 Q9Y619 1 |
| Endochondral ossification 0.3720200555197211 0.3048893617038636 0.7604504183906802 1.0 1.0 9 P31749 1 |
| Endochondral ossification with skeletal dysplasias 0.3720200555197211 0.3048893617038636 0.7604504183906802 1.0 1.0 9 P31749 1 |
| Hepatitis c and hepatocellular carcinoma 0.3632609257850096 0.297759633230453 0.765886625780098 1.0 1.0 10 P31749 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.3447614977718138 0.2956257930278784 0.7675158736189429 1.0 1.0 13 Q5JRA6,P13674,Q96AY3,P07237,Q32P28,O75718 6 |
| Ras signaling 0.3250716134501216 0.2925958219659842 0.7698311076675011 1.0 1.0 32 P31749,P31751 2 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.6226694288251016 0.2827728786802313 0.7773509458392995 1.0 1.0 2 O15111 1 |
| Netrinunc5b signaling pathway 0.3411414617504973 0.2773831283878664 0.7814859351515975 1.0 1.0 13 P31749 1 |
| Cohesin complex cornelia de lange syndrome 0.3111725630434194 0.2464650762064696 0.8053222358665191 1.0 1.0 19 P25054,P30154,Q9UQE7,P06493 4 |
| Thyroid stimulating hormone tsh signaling pathway 0.316155830867487 0.2409245967915792 0.809613558070915 1.0 1.0 18 P16220,P31749 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.3611584191261231 0.2390570855341776 0.8110613178395396 1.0 1.0 8 O14964,P31943,P27361 3 |
| Il5 signaling pathway 0.3340826215405625 0.2370605319617175 0.8126098306184062 1.0 1.0 12 P31749,Q15418,P49841 3 |
| 16p112 distal deletion syndrome 0.3565500889152362 0.2081318631092732 0.8351260087227586 1.0 1.0 7 Q9H2V7,P49411,P20339,Q99873,P20338,P62993 6 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3160851173760255 0.1757686281231037 0.8604757170128821 1.0 1.0 15 P31749,P49841,O15111,P62993,P27361,P11802 6 |
| Cholesterol biosynthesis pathway 0.3201736613007769 0.1741275324572977 0.8617652359486911 1.0 1.0 12 P48449,Q16850,Q15800 3 |
| Microtubule cytoskeleton regulation 0.2982234532770024 0.1702214677867789 0.8648359692402483 1.0 1.0 19 P25054,P31749 2 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.311165511337345 0.1574091815572336 0.8749223778265969 1.0 1.0 43 P23588,P31749,P31751,P49841,P49815,P30154,Q15382,Q9UBI6,P07942,Q16543,P13807,P62993,P16220 13 |
| Gdnfret signaling axis 0.4328004736530476 0.1467944600590025 0.8832942575465306 1.0 1.0 3 P35222,Q9BW83 2 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3016677790043798 0.1370934080463211 0.8909569628902958 1.0 1.0 17 O14641,P25054 2 |
| Tcell receptor tcr signaling pathway 0.2874975566709885 0.1338938946396522 0.8934864781861005 1.0 1.0 21 P08670,P31749 2 |
| Malignant pleural mesothelioma 0.2855019702311337 0.130544702550522 0.8961354891946378 1.0 1.0 72 P23588,P31751,Q15382,P07942,Q9Y297,P11802,Q07820,P31749,P51812,Q04637,Q13257,O15294,P49841,P25054,Q15047,P16220,P49815,P62993,O14641,P09429,Q15418 21 |
| Map3k1 role in promoting and blocking gonadal determination 0.343898104265389 0.1193621997140492 0.9049884074042908 1.0 1.0 5 P35222,P28482,Q13464,P49841 4 |
| Wnt signaling pathway and pluripotency 0.2936846338079588 0.1180904745570071 0.9059959708431002 1.0 1.0 18 O14641,P25054 2 |
| Calcium regulation in cardiac cells 0.2904003438440922 0.1155325659950695 0.9080230093604152 1.0 1.0 25 Q14012,P62942,Q04917,P05026,P20020,Q9UBI6,Q13555,P0DP25,P16615,P31946,Q9Y3B8,P10644,P63104 13 |
| Sting pathway in kawasakilike disease and covid19 0.4100059206631147 0.1114157840271956 0.9112866441437896 1.0 1.0 3 O15111,Q04864 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2969056492330916 0.1046543573907243 0.916650080522862 1.0 1.0 32 P48449,Q16850,Q9NR31,P31749,Q9HCL2,P16220,Q15437,Q8WTV0 8 |
| Ppar signaling pathway 0.2816515127863168 0.1009148491046528 0.9196180554038362 1.0 1.0 21 Q15067,Q9UKU0 2 |
| Mapk signaling pathway 0.2993074898446761 0.086333630378061 0.9312012050935364 1.0 1.0 39 P16949,P31749,Q9Y4G8,P31751,Q9H2K8 5 |
| Nucleotide metabolism 0.3030018865784394 0.0827777788919636 0.9340282383518204 1.0 1.0 11 P31350 1 |
| Ethanol effects on histone modifications 0.2950006722815181 0.0726502801018638 0.9420844146641516 1.0 1.0 12 O94788,P00374 2 |
| Pdgfrbeta pathway 0.3083308627334683 0.0718427763279461 0.942727030165068 1.0 1.0 8 P45985,P19174,P19525,P42224,P62993,P27361,Q02750 7 |
| Nuclear receptors in lipid metabolism and toxicity 0.4844628588339823 0.0701084159780742 0.9441073682055248 1.0 1.0 2 P08183 1 |
| Peroxiredoxin 2 induced ovarian failure 0.3611604499703906 0.0577237728210693 0.9539686572925852 1.0 1.0 3 Q9UGN5,Q07812 2 |
| Inclusion body myositis 0.3573120189461224 0.0546672810064475 0.9564035363409364 1.0 1.0 3 P05067,Q92542 2 |
| Lncrnamediated mechanisms of therapeutic resistance 0.4598993785143595 0.0537071373586005 0.9571684962214506 1.0 1.0 2 P08183 1 |
| Proximal tubule transport 0.2981919719025734 0.0486614494410998 0.961189098348258 1.0 1.0 9 Q9UI12,Q9Y5K8,P05023 3 |
| Liver x receptor pathway 0.4477656111275583 0.0474131932562296 0.9621839141485268 1.0 1.0 2 O00767 1 |
| Ciliary landscape 0.2503865150220682 0.0324121305473961 0.9741433887935552 1.0 1.0 108 P07197,Q13409,Q9Y4W6,Q96P70,Q9Y266,P42704,Q9NTJ3,O15173,O95721,Q9UBW8,Q99567,Q9NVA1,O43464,Q99627,P61201,P25054,P08670,P51665,O43805,Q13868,P60660,Q8IUR7,Q9BT78,P33991,Q8TAG9,P07196,Q96A65,Q15555,A0AVF1,P43246 30 |
| Disorders of folate metabolism and transport 0.291220428090523 0.0308001922057845 0.97542888713589 1.0 1.0 8 P00374 1 |
| Mirna regulation of p53 pathway in prostate cancer 0.2936803887659288 0.0280047741447757 0.9776583434246682 1.0 1.0 4 O14681 1 |
| Mapk pathway in congenital thyroid cancer 0.3078744819419741 0.0276903952831525 0.9779090842214804 1.0 1.0 3 P27361,Q02750 2 |
| Eicosanoid synthesis 0.3749630068067574 0.0275638840345687 0.978009987078578 1.0 1.0 2 Q9H7Z7 1 |
| Retinoblastoma gene in cancer 0.2924563977849002 0.0242705159056431 0.9806368310995656 1.0 1.0 47 P20248,Q14527,Q9Y619,P16949,P31350,O75419,P33993,P25205,Q14566,P00374,P06493,P26583,P09429,Q16204,P40937,Q9UQE7,P33991,P11802 18 |
| Mitochondrial complex i assembly model oxphos system 0.2816203708026471 0.0222714142460458 0.9822314513517296 1.0 1.0 31 Q7L592,O95168,O75306,Q9NPL8,Q9BQ95,O43674,P56556,P03886,O96000,O43676,Q96CU9 11 |
| Oxidative damage response 0.2802132701421753 0.0167407595642344 0.9866434302803556 1.0 1.0 5 P60953,P45985,O95551,O95429 4 |
| Signal transduction through il1r 0.2642535423384115 0.0089619204862361 0.9928495177253956 1.0 1.0 4 Q9BQ95 1 |
|
|
